Enterome logo

Enterome

ID: 5635856

Developer of OncoMimics™ immunotherapy to treat follicular lymphoma.

15

Funding Rounds

$351.5m

Money raised

Overview

Developer of OncoMimics™ immunotherapy to treat follicular lymphoma.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Enterome has raised a total of $295.22m in funding over 15 rounds.

Key Insights:

  • Enterome Venture Round, June 2025: $19m
  • Enterome October 2023 Series F Funding Round: $3.2m
  • Enterome July 2022 Series F Funding Round: $43m
  • Enterome , June 2020: $51.9m
  • Enterome June 2020 Series E Funding Round: $52m
  • Enterome Series D round, January 2017: $38.5m
  • Enterome January 2017 Series D Funding Round: $35m
  • Enterome April 2016 Series C Funding Round: $16m
  • Enterome May 2014 Series B Funding Round: $12m
  • Enterome March 2012 Series A Funding Round: $8.2m
  • Enterome March 2012 Series A Funding Round: $8.2m
  • Enterome Series A round: $6.62m
  • Enterome January 2011 Seed Funding Round: $1.6m
  • Enterome Series B round May 2014: $10m
  • Enterome Series E round June 2020: $46.3m